We Shouldn't Wait for a Breakthrough in the Covid-19 Pandemic

Gary P. Pisano

Article | Harvard Business Review Digital Articles | May 6, 2020

We Shouldn't Wait for a Breakthrough in the Covid-19 Pandemic

Abstract

The ultimate solutions to the Covid-19 crisis may be big breakthroughs in building massive test and trace capacity and developing vaccines and drug remedies. But in the meantime, we should not ignore the potential cumulative impact of the many small things we already know how to do or might try that together could make a big dent in the current crisis. Big problems typically get tackled through a series of small solutions, each of which on its own may not seem particularly important but that together can have a huge impact. Creating and implementing a “small steps” strategy, however, will require strong leadership.

Keywords: COVID-19; Health Pandemics; Strategy; Leadership;

Format: Electronic

Find at Harvard Read Now

Citation:

Pisano, Gary P. "We Shouldn't Wait for a Breakthrough in the Covid-19 Pandemic." Harvard Business Review Digital Articles (May 6, 2020).

For more than two decades, scientific advances have been driving profound changes in drug discovery and the drug industry itself. This case provides an overview and description of these technical and scientific advances. Written for the nonscientific reader, it may be used as companion reading for other case materials that require basic knowledge of the tools, techniques, and approaches used in the pharmaceutical and biotechnology industries.

The best practices in supply chain and operations management can help health care providers cope with the surge in patients and the supply shortages. They will help them create a comprehensive strategy aimed at both the demand- and supply-side roots of the problem. The purpose of this article is to assist health care leaders and their organizations in anticipating and preempting problems rather than continuing to react to them.

Article | Industrial and Corporate Change | April 2020

Long-term Firm Growth: An Empirical Analysis of U.S. Manufacturers 1959–2015

Giovanni Dosi, Marco Grazzi, Daniele Moschella, Gary P. Pisano and Federico Tamagni

Firm growth is an essential feature of market economies, shaping together macroeconomic performance and the evolution of industry structures. As a potential indicator of organizational “fitness” within a competitive environment, firm growth is also a central concern to both the practice and theory of business strategy. Despite both its theoretical and practical importance, though, growth remains a poorly understood property of firms. While previous studies have documented the fat-tailed nature of firm growth rates, we know far less about the patterns of growth rates over long periods of time. For instance, do “fast growers” tend to maintain their relative growth rates advantages over long periods or is superior growth a transitory phenomenon? Is, as predicted by evolutionary and capability-based theories of the firm, the process of firm growth path-dependent or is it more akin to a random walk? The answers to these questions are central to building a robust theory of firm growth. This article attempts to address this gap in our empirical knowledge of firm growth using a dataset that spans 50 years, which allows the abandonment of the assumption, common to all incumbent studies, that the stochastic paths of all firms stem from the same generating process. These exploratory results indicate that growth rate persistence is there and may be even substantial for some firms, but it is rare. We also study the links between the micro-properties of firm growth within sectors and the patterns of aggregate growth of these same sectors. Indeed, we find circumstantial but widespread evidence that heterogeneity across firms correlates with industry dynamism.

Keywords: firm growth; Organizations; Growth and Development; Theory; Analysis; Production; Data and Data Sets;

Citation:

Dosi, Giovanni, Marco Grazzi, Daniele Moschella, Gary P. Pisano, and Federico Tamagni. "Long-term Firm Growth: An Empirical Analysis of U.S. Manufacturers 1959–2015." Industrial and Corporate Change 29, no. 2 (April 2020): 309–332. View Details

Cite View Details Find at Harvard Register to Read

Faculty & Research

We Shouldn't Wait for a Breakthrough in the Covid-19 Pandemic

Abstract

Citation:

About the Author

More from the Author